Mannatech (NASDAQ:MTEX) Coverage Initiated by Analysts at StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX) in a research report issued to clients and investors on Tuesday. The brokerage set a “buy” rating on the stock.

Mannatech Trading Up 1.5 %

NASDAQ:MTEX opened at $7.75 on Tuesday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.62 and a current ratio of 1.17. The firm has a market cap of $14.61 million, a P/E ratio of -8.71 and a beta of 1.17. The firm has a 50-day simple moving average of $7.41 and a 200-day simple moving average of $7.69. Mannatech has a one year low of $6.75 and a one year high of $10.81.

Mannatech (NASDAQ:MTEX) last posted its quarterly earnings data on Tuesday, August 13th. The company reported ($0.33) EPS for the quarter. The firm had revenue of $27.74 million for the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%.

Insider Buying and Selling

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $7.75, for a total transaction of $126,232.00. Following the sale, the director now owns 54,721 shares of the company’s stock, valued at approximately $424,087.75. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 41.50% of the stock is currently owned by company insiders.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.